These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 1066997

  • 21. The immunopathology of acquired myasthenia gravis.
    Engel AG, Sahashi K, Fumagalli G.
    Ann N Y Acad Sci; 1981; 377():158-74. PubMed ID: 6951470
    [Abstract] [Full Text] [Related]

  • 22. [Histochemical findings of and fine structural changes in motor endplates in diseases with neuromuscular transmission abnormalities].
    Yoshimura T, Motomura M, Tsujihata M.
    Brain Nerve; 2011 Jul; 63(7):719-27. PubMed ID: 21747142
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Ultrastructural studies on the acetylcholine receptor at motor end plates of normal and pathologic muscles.
    Porter CW, Barnard EA.
    Ann N Y Acad Sci; 1976 Jul; 274():85-107. PubMed ID: 786117
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations.
    Engel AG, Lambert EH, Howard FM.
    Mayo Clin Proc; 1977 May; 52(5):267-80. PubMed ID: 870771
    [Abstract] [Full Text] [Related]

  • 27. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
    Meinl E, Klinkert WE, Wekerle H.
    Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
    [Abstract] [Full Text] [Related]

  • 28. Age-related resistance to experimental autoimmune myasthenia gravis in rats.
    Graus YM, Verschuuren JJ, Spaans F, Jennekens F, van Breda Vriesman PJ, De Baets MH.
    J Immunol; 1993 May 01; 150(9):4093-103. PubMed ID: 8386206
    [Abstract] [Full Text] [Related]

  • 29. Neostigmine-induced alterations at the mammalian neuromuscular junction. II. Ultrastructure.
    Hudson CS, Rash JE, Tiedt TN, Albuquerque EX.
    J Pharmacol Exp Ther; 1978 May 01; 205(2):340-56. PubMed ID: 641832
    [Abstract] [Full Text] [Related]

  • 30. End-plate potentials in experimental autoimmune myasthenia gravis in rats.
    Lambert EH, Lindstrom JM, Lennon VA.
    Ann N Y Acad Sci; 1976 May 01; 274():300-18. PubMed ID: 1066990
    [Abstract] [Full Text] [Related]

  • 31. In vitro quantitative autoradiography of [125I]alpha-bungarotoxin binding at the motor end-plates of experimental autoimmune myasthenia gravis.
    Motomura M, Niwa M, Kataoka Y, Ootsuru I, Yoshimura T, Tsujihata M, Nagataki S.
    Neurosci Lett; 1992 Aug 31; 143(1-2):139-42. PubMed ID: 1436658
    [Abstract] [Full Text] [Related]

  • 32. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis.
    Lindstrom JM, Einarson BL, Lennon VA, Seybold ME.
    J Exp Med; 1976 Sep 01; 144(3):726-38. PubMed ID: 182896
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Engineered agrin attenuates the severity of experimental autoimmune myasthenia gravis.
    Li Z, Li M, Wood K, Hettwer S, Muley SA, Shi FD, Liu Q, Ladha SS.
    Muscle Nerve; 2018 May 01; 57(5):814-820. PubMed ID: 29193204
    [Abstract] [Full Text] [Related]

  • 36. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release.
    Engel AG, Lambert EH, Gomez MR.
    Ann Neurol; 1977 Apr 01; 1(4):315-30. PubMed ID: 214017
    [Abstract] [Full Text] [Related]

  • 37. Presynaptic function modified by acetylcholine-receptor interaction in experimental autoimmune myasthenia gravis.
    Takamori M, Sakato S, Okumura S.
    J Neurol Sci; 1984 Apr 01; 66(2-3):245-53. PubMed ID: 6099402
    [Abstract] [Full Text] [Related]

  • 38. In vivo imaging shows loss of synaptic sites from neuromuscular junctions in a model of myasthenia gravis.
    Rich MM, Colman H, Lichtman JW.
    Neurology; 1994 Nov 01; 44(11):2138-45. PubMed ID: 7969973
    [Abstract] [Full Text] [Related]

  • 39. Neostigmine-induced end-plate proliferation in the rat. A study using supra-vital methylene blue.
    Schwartz MS, Sargeant MK, Swash M.
    Neurology; 1977 Mar 01; 27(3):289-93. PubMed ID: 66646
    [Abstract] [Full Text] [Related]

  • 40. Experimental neonatal autoimmune myasthenia gravis: an immunohistochemical, ultrastructural and electrophysiological study of the motor end-plate.
    Tetsuo N, Tsujihata M, Satoh A, Yoshimura T, Nakamura T, Seto M, Nagataki S.
    J Neurol Sci; 1995 Oct 01; 132(2):97-104. PubMed ID: 8543956
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.